DCGI approaches Serum Institute to update convention for stage 2, 3 preliminaries of Oxford COVID-19 vaccine Kumar Jeetendra | July 30, 2020 The Subject Expert Committee (SEC) on COVID-19 that held its meeting Tuesday deliberated about the program by SII and requested that the Pune-based company to revise its own protocol to the stage 2 and 3 clinical trials, aside from needing some extra details. On Wednesday evening, SII filed a revised protocol for running the trials …
Waterloo Technology profiles Compounds in blood of COVID-19 Sufferers Kumar Jeetendra | July 29, 2020 A world-leading University of Waterloo spinoff company, that decodes blood samples for potential treatments for illnesses such as cancer and COVID-19, is expanding operations with the support of a 5-million USD investment. Bin Ma, a University of Waterloo computer engineering professor who co-founded Rapid Novor at 2015, says that the company’s technologies is the most …
Roche’s Tocilizumab neglects to meet essential end focuses for COVID-19 related pneumonia Kumar Jeetendra | July 29, 2020 Swiss Drug maker Roche on July 29 declared that its drug Actemra (Tocilizumab), which has emerged as a widely prescribed drug for treating hosiptalised COVID-19 patients, didn’t fulfill its primary endpoint of improved clinical standing in hospitalised adult patients with acute COVID-19 related pneumonia. In addition, the primary secondary endpoint of decreased patient mortality week …
Extra 6.7 million kids under 5 could experience the ill effects of squandering due to COVID-19: UNICEF Kumar Jeetendra | July 28, 2020 Another 6.7 million kids under the age of five round the globe might suffer from squandering this year on account of this socioeconomic effects of the COVID-19 outbreak, the UNICEF warned on Tuesday. According to the UNICEF, in India, there continue to be about 20 million children below five decades old that are suffering from …
Artificial Intelligence detects Prostate Cancer With Near-Perfect Accuracy Kumar Jeetendra | July 28, 2020 A study in the University of Pittsburgh shows the highest accuracy thus far in understanding and characterizing prostate cancer using an artificial intelligence (AI) application.1 “Humans are great at recognizing anomalies, but they have their particular biases or previous experience,” says senior writer Rajiv Dhir, MD, MBA, chief pathologist and vice chair of pathology at …
Study: Mosquitoes species Have Been Drawn and repelled by light at different times Daily Kumar Jeetendra | July 28, 2020 In a new study, researchers found that nighttime – versus day-biting species of mosquitoes have been behaviorally attracted and repelled by different colors of light at different times of day. Mosquitoes are one of important disease vectors impacting animals and humans around the globe and also the findings have important implications for applying light to …
WHO says COVID-19 pandemic is ‘one major wave’, not occasional Kumar Jeetendra | July 28, 2020 The World Health Organization on Tuesday warned against complacency about new coronavirus transmission at the northern hemisphere summer, stating that this virus did not act like influenza that tended to follow seasonal trends. “Folks are still thinking about seasons. What we all need to get our heads around is this is a new virus and. …
WHO says COVID-19 by a wide margin its most noticeably terrible worldwide wellbeing crisis Kumar Jeetendra | July 27, 2020 The new coronavirus pandemic which has infected over 16 million individuals is the worst global health emergency the World Health Organization (WHO) has confronted, its own director general Tedros Adhanom Ghebreyesus said on Monday. Just with rigorous adherence to health measures, from wearing masks to avoiding crowds, would the planet figure out how to conquer …
Researchers decode how coronavirus particles ‘camouflage’ in have cell Kumar Jeetendra | July 27, 2020 Researchers, including the ones of Indian-origin, have solved the structure of a molecule which the novel coronavirus uses to make its genetic sequence look like a part of the host’s own, an advance which may cause the development of new antiviral drugs against COVID-19. The researchers from the The University of Texas Health Science Center …
Nitric oxide treatment can be essential in the battle against COVID-19 Kumar Jeetendra | July 27, 2020 Nitric oxide therapy could be critical in the world’s struggle against SARS-CoV-2, the coronavirus which causes COVID-19, according to a review by the George Washington University (GW). Nitric oxide is an antimicrobial and anti inflammatory molecule with key roles in pulmonary arterial role in the context of viral infections as well as other pulmonary diseases. …
Analysts recognize anticoagulation operator that stifles SARS-CoV-2 replication in vitro Kumar Jeetendra | July 27, 2020 Effective antivirals with secure clinical profile are urgently needed to improve the overall prognosis. In an analysis of a randomly collected cohort of 124 patients using COVID-19, the authors discovered that hypercoagulability according to elevated levels of D-dimers was associated with illness severity. By calculating of a U.S. FDA approved drug library, the authors identified …
AdvaMed Unveils National Covid-19 Testing Registry Kumar Jeetendra | July 26, 2020 The Advanced Medical Technology Association (AdvaMed) has made a detailed, nationwide covid-19 diagnostic supply registry to assist state and federal governments in their own wing responses. The national registry has been launched in partnership with 13 commercial diagnostics makers: Abbott, BD, bioMérieux, Bio-Rad, Beckman Coulter, Cepheid, Hologic, Ortho Clinical Diagnostics, Qiagen, Roche Diagnostics, Sekisui Diagnostics, …
